MAGEH1 and neoplasm: In whole-tumor samples, overexpression of LAYN, MAGEH1, and CCR8, three of the most enriched genes in tumor-infiltrating Treg signature genes, was associated with a worse 5-year survival of CRC and NSCLC patients, pinpointing these genes as potential therapeutic targets.